Nils Rudqvist

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Nils Rudqvist

Nov 19, 2024, 20:44 | Blog

Dhan Chand: Expanding treatment options through innovative iNKT cell therapy combinations

Dhan Chand, Vice President of Research at Agenus, shared a post on LinkedIn: "Novel cell…

Apr 30, 2024, 12:41 | Insight

Nils Rudqvist: Full support for Sandra Demaria as she is running to become the next SITC vice president!

Nils Rudqvist, Director and Scientific Strategic Program Manager at Agenus, shared a post on LinkedIn:…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023